May 16 (Reuters) - Johnson & Johnson ( JNJ ) on Thursday
said it would acquire privately held Proteologix for $850
million in cash, with potential for an additional milestone
payment.
(Reporting by Sriparna Roy in Bengaluru; Editing by Anil
D'Silva)